Status:
UNKNOWN
Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Graves Disease
Eligibility:
All Genders
20+ years
Brief Summary
Graves' disease (MIM 27500) is the leading cause of hyperthyroidism worldwide. The prevalence of Graves' disease is quite high (2.7% in women), and there is solid evidence of genetic predisposition. D...
Eligibility Criteria
Inclusion
- Patients with Graves disease
Exclusion
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02210741
Start Date
August 1 2014
End Date
February 1 2024
Last Update
August 7 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, Taiwan, 100